GOOGL
67
3
AEP
56
-2
TXN
33
3
DAL
48
-2
HRL
29
2
ILMN
36
10
COF
60
-4
PBI
30
7
GM
61
-4
ECL
84
14
XYL
43
-4
ZTS
49
20
TRV
43
-3
JNPR
56
2
FIS
50
-3
SNA
53
-3
T
45
3
HBAN
33
2
HPE
46
-5
PRU
50
2
GOOGL
67
3
AEP
56
-2
TXN
33
3
DAL
48
-2
HRL
29
2
ILMN
36
10
COF
60
-4
PBI
30
7
GM
61
-4
ECL
84
14
XYL
43
-4
ZTS
49
20
TRV
43
-3
JNPR
56
2
FIS
50
-3
SNA
53
-3
T
45
3
HBAN
33
2
HPE
46
-5
PRU
50
2
Financhill
Back

Garmin Vs. Ultragenyx Pharmaceutical Industry Stock Comparison

Buy
59

GRMN
Garmin

Last Price:
161.41
Seasonality Move:
7.93%
Sell
43

RARE
Ultragenyx Pharmaceutical

Last Price:
39.58
Seasonality Move:
3.65%
Buy
59
Garmin (GRMN) is a Buy

Is Garmin a Buy, Sell or Hold?

  • The current Garmin [GRMN] share price is $161.45. The Score for GRMN is 59, which is 18% above its historic median score of 50, and infers lower risk than normal.
  • GRMN is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
43
Ultragenyx Pharmaceutical (RARE) is a Sell

Is Ultragenyx Pharmaceutical a Buy, Sell or Hold?

  • The current Ultragenyx Pharmaceutical [RARE] share price is $39.60. The Score for RARE is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
  • RARE is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

GRMN Stock Price Chart

What is Garmin's stock price today?

  • The Garmin share price today is $161.45
    The current trend is relatively stagnant and GRMN is experiencing buying pressure, which is a positive indicator for future bullish movement.

RARE Stock Price Chart

What is Ultragenyx Pharmaceutical's stock price today?

  • The Ultragenyx Pharmaceutical share price today is $39.60
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RARE is experiencing buying pressure, which is a positive indicator for future bullish movement.

GRMN Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.1 Sell
Relative Strength Index (14 RSI): 49.22 Sell
Chaikin Money Flow: 1296836 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (160.4 - 166.86) Sell
Bollinger Bands (100): (132.67 - 163.13) Buy

RARE Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.73 Sell
Relative Strength Index (14 RSI): 45.77 Sell
Chaikin Money Flow: 722527 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (38.99 - 42.29) Sell
Bollinger Bands (100): (41.03 - 48.83) Sell

GRMN Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 161.2 Buy
20-day SMA: 162.34 Sell
50-day SMA: 158.76 Buy
200-day SMA: 131.76 Buy
8-day EMA: 161.25 Buy
20-day EMA: 162.06 Sell
50-day EMA: 158.45 Buy
200-day EMA: 137.09 Buy

RARE Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 40.38 Sell
20-day SMA: 40.41 Sell
50-day SMA: 41.94 Sell
200-day SMA: 42.46 Sell
8-day EMA: 39.76 Sell
20-day EMA: 40.54 Sell
50-day EMA: 42.03 Sell
200-day EMA: 43.46 Sell

Garmin Earnings Growth & GRMN Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.08 per share, an increase next quarter of $0.20 per share, an increase this year of $0.41 per share, and an increase next year of $0.50 per share.

Ultragenyx Pharmaceutical Earnings Growth & RARE Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.49 per share, an increase next quarter of $0.01 per share, an increase this year of $0.90 per share, and an increase next year of $1.07 per share.

Garmin Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Ultragenyx Pharmaceutical Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):